HAVCR2 and neoplasm: We assessed the expression of TIM-3 by tumor cells – defined as pancytokeratin and/or PAX8 positive cells—and tested its association with plasma sTIM-3 in a subset of BIONIKK participants (n = 22) (Fig. 4A).